pindolol has been researched along with epanolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Simon, G; Wittig, VJ | 1 |
| Clarke, BF; Ewing, DJ; Harry, JD; Neilson, JM; Reid, W; Smith, HJ | 1 |
2 trial(s) available for pindolol and epanolol
| Article | Year |
|---|---|
Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Benzeneacetamides; Exercise Test; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Norepinephrine; Pindolol; Propanolamines; Radioimmunoassay; Random Allocation; Renin; Sympathomimetics | 1987 |
Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzeneacetamides; Blood Glucose; Circadian Rhythm; Diabetic Neuropathies; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Pindolol; Propanolamines; Tremor | 1987 |
1 other study(ies) available for pindolol and epanolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |